Fulgent Genetics, Inc. (FLGT) Social Stream
FULGENT GENETICS INC (FLGT) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering FULGENT GENETICS INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-09-28 | 1 | $141 | $141 | $141 | $33.04 | 326.76% |
2022-01-24 | 1 | $125 | $125 | $125 | $33.04 | 278.33% |
2022-02-04 | 2 | $125 | $80 | $102.5 | $33.04 | 210.23% |
2022-02-24 | 2 | $123 | $80 | $101.5 | $33.04 | 207.2% |
2022-04-19 | 2 | $123 | $85 | $104 | $33.04 | 214.77% |
2022-05-04 | 2 | $112 | $85 | $98.5 | $33.04 | 198.12% |
2022-05-23 | 2 | $112 | $70 | $91 | $33.04 | 175.42% |
2022-08-17 | 1 | $70 | $70 | $70 | $33.04 | 111.86% |
2022-11-14 | 1 | $65 | $65 | $65 | $33.04 | 96.73% |
2022-11-18 | 2 | $65 | $45 | $55 | $33.04 | 66.46% |
2022-12-08 | 2 | $45 | $40 | $42.5 | $33.04 | 28.63% |
The Trend in the Analyst Price Target
Over the past 31 weeks, FLGT's average price target has gone down $56.
FLGT reports an average of 56.97% for its upside potential over the past 44 weeks.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-05-04 | 2 | 112 | 85 | 98.5 | 58.73 | 67.72% |
2022-05-23 | 2 | 70 | 70 | 70.0 | 56.45 | 24% |
2022-05-23 | 1 | 70 | 70 | 70.0 | 56.45 | 24% |
2022-08-17 | 1 | 70 | 70 | 70.0 | 48.06 | 45.65% |
2022-11-14 | 2 | 65 | 65 | 65.0 | 35.92 | 80.96% |
FLGT Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.5 | 0 | 1 | 1 | 0 | 0 | 2 |
The Trend in the Broker Recommendations
Over the past 28 months, FLGT's average broker recommendation rating worsened by 0.83.
The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.
- In the context of all US stocks, FULGENT GENETICS INC's number of analysts covering the stock is greater than 34.2% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, FULGENT GENETICS INC's variance in analysts' estimates is lower than -110.44% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, FULGENT GENETICS INC's upside potential (average analyst target price relative to current price) is higher than 1153.72% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, FULGENT GENETICS INC's average analyst price target is higher than 1136.5% of them.
In the Healthcare industry, NVTA, CDNA, and VCYT are the three stocks most similar to FULGENT GENETICS INC regarding the price target and analyst recommendation information presented here.
View All Top Stocks by Price Target
Make investment decisions regarding FLGT using the data that counts. Try POWR Ratings for free.